News Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
1.4 ^USD	-50.62%		-61.22%	-85.73%

02:05pm	Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	CI
Apr. 10	Goldman Sachs Cuts Price Target on Pacific Biosciences of California to $7 From $9, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance	08:06am	PR
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	08:05am	CI
Goldman Sachs Cuts Price Target on Pacific Biosciences of California to $7 From $9, Maintains Buy Rating	Apr. 10	MT
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	Mar. 27	PR
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	Mar. 27	CI
PacBio Grants Equity Incentive Award to New Employee	Mar. 22	PR
Transcript : Pacific Biosciences of California, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 10:15 AM	Mar. 12
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions	Mar. 12	PR
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	Mar. 12	CI
PacBio to Present at Upcoming Investor Conferences	Feb. 26	PR
Federal Circuit Affirms Claim Construction And How It Applies	Feb. 20	AQ
UBS Trims Pacific Biosciences of California Price Target to $12 From $12.50, Maintains Buy Rating	Feb. 16	MT
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours	Feb. 15	MT
Transcript : Pacific Biosciences of California, Inc., Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q4 Revenue $58.4M, vs. Street Est of $58.3M	Feb. 15	MT
Pacific Biosciences: Q4 Earnings Snapshot	Feb. 15	AQ
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results	Feb. 15	PR
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch	Feb. 13	PR
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	Feb. 05	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Summary

Filters